To ask the Minister for Women and Equalities, what assessment her Department has made of the effect that the decision of the High Court on 1 December 2020, on requiring informed consent for giving puberty blockers and hormones to children aged under 16, will have on the safety and protection of children.
The NHS has previously recognised the need for a review of how to best meet the needs of children and young people with gender incongruence, which is why in September 2020, Dr Hilary Cass was asked to carry out an independent review of the gender identity development service. The review will be wide-ranging in scope, with a focus on how care can be improved for children and young people. The Tavistock is also required to undertake a number of urgent actions in response to the CQC’s recent finding that its child gender-identity service is ‘inadequate’.
The Tavistock and Portman appeal is subject to ongoing legal proceedings, as such the Government is unable to comment on the specifics of the case at this time. However, we will follow the proceedings closely and continue to review its impact on policy related to this area.